Motility of cancer cells. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Neoplastic Stem Cells Flagella Cell Line Spermatozoa Breast Epithelial Cells Prostate HeLa Cells Fibroblasts Cell Nucleus Cells, Cultured Mitochondria Pseudopodia Spheroids, Cellular Neoplastic Cells, Circulating Colon Cytoskeleton

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae

Diseases40

Breast Neoplasms Neoplasm Invasiveness Colonic Neoplasms Neoplasms Ovarian Neoplasms Lung Neoplasms Neoplasm Metastasis Pancreatic Neoplasms Stomach Neoplasms Prostatic Neoplasms Carcinoma Adenocarcinoma Colorectal Neoplasms Urinary Bladder Neoplasms Cell Transformation, Neoplastic Carcinoma, Non-Small-Cell Lung Disease Progression Uterine Cervical Neoplasms Carcinoma, Squamous Cell Neoplasms, Hormone-Dependent Neovascularization, Pathologic Endometrial Neoplasms Genetic Predisposition to Disease Esophageal Motility Disorders Liver Neoplasms Bone Neoplasms Carcinoma, Small Cell Esophageal Neoplasms Mammary Neoplasms, Experimental Neoplasm Recurrence, Local Neoplasms, Glandular and Epithelial Mouth Neoplasms Rectal Neoplasms Head and Neck Neoplasms Carcinoma, Pancreatic Ductal Neoplasms, Experimental Melanoma Thyroid Neoplasms Neoplastic Cells, Circulating Disease Models, Animal

Chemicals and Drugs85

Antineoplastic Agents RNA, Small Interfering Neoplasm Proteins RNA, Messenger Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Receptors, Estrogen Receptor, erbB-2 Tumor Markers, Biological Proto-Oncogene Proteins c-akt DNA, Neoplasm Cancer Vaccines Receptor, Epidermal Growth Factor Tamoxifen Cisplatin Receptors, Androgen Enzyme Inhibitors Tumor Suppressor Proteins RNA, Neoplasm Paclitaxel Transcription Factors MicroRNAs Proto-Oncogene Proteins Anticarcinogenic Agents Androgens DNA-Binding Proteins Proto-Oncogene Proteins c-bcl-2 Estrogen Receptor alpha Protein-Serine-Threonine Kinases Antigens, Neoplasm Cadherins Protein Kinase Inhibitors Antibodies, Monoclonal Membrane Proteins Prostate-Specific Antigen Apoptosis Regulatory Proteins Phosphatidylinositol 3-Kinases Caspase 3 Caspases beta Catenin Receptors, Progesterone Fluorouracil Antimetabolites, Antineoplastic Nuclear Proteins Plant Extracts Antineoplastic Agents, Hormonal DNA Primers Antibiotics, Antineoplastic Estrogens Inhibitor of Apoptosis Proteins Cell Cycle Proteins Estradiol Cyclin-Dependent Kinase Inhibitor p21 Estrogen Antagonists Cyclin D1 Antigens, CD44 Quinazolines Indoles Hydroxamic Acids NF-kappa B Reactive Oxygen Species Deoxycytidine TNF-Related Apoptosis-Inducing Ligand Poly(ADP-ribose) Polymerases Cyclooxygenase 2 Extracellular Signal-Regulated MAP Kinases Carrier Proteins bcl-2-Associated X Protein Azacitidine Estrogen Receptor Modulators Histone Deacetylase Inhibitors TOR Serine-Threonine Kinases Vascular Endothelial Growth Factor A PTEN Phosphohydrolase Protein Isoforms Nitriles Intracellular Signaling Peptides and Proteins Taxoids Antibodies, Monoclonal, Humanized Proto-Oncogene Proteins c-myc STAT3 Transcription Factor ras Proteins Telomerase Matrix Metalloproteinase 9 Recombinant Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment49

Sperm Motility Early Detection of Cancer Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Drug Screening Assays, Antitumor Transfection Neoplasm Transplantation Transplantation, Heterologous Gene Expression Profiling Gene Knockdown Techniques Flow Cytometry Models, Biological Oligonucleotide Array Sequence Analysis Immunohistochemistry Prognosis Antineoplastic Combined Chemotherapy Protocols Tumor Burden Survival Analysis Inhibitory Concentration 50 Survival Rate Molecular Targeted Therapy Neoplasm Staging Immunoblotting Tumor Stem Cell Assay Real-Time Polymerase Chain Reaction Retrospective Studies Follow-Up Studies Risk Mammary Neoplasms, Experimental Combined Modality Therapy Microscopy, Fluorescence Prospective Studies Genetic Therapy Registries Immunoprecipitation Disease-Free Survival Immunoenzyme Techniques Drug Delivery Systems Tissue Array Analysis Risk Assessment Sensitivity and Specificity Kaplan-Meier Estimate Chemotherapy, Adjuvant Odds Ratio Neoplasms, Experimental Reproducibility of Results Disease Models, Animal Multivariate Analysis

Psychiatry and Psychology1

Phenomena and Processes55

Sperm Motility Gastrointestinal Motility Gene Expression Regulation, Neoplastic Cell Movement Cell Proliferation Apoptosis Drug Resistance, Neoplasm Cell Survival Signal Transduction Cell Division Down-Regulation Transfection Cell Cycle RNA Interference Cell Growth Processes Mutation Phosphorylation Dose-Response Relationship, Drug Up-Regulation Promoter Regions, Genetic Gene Silencing Cell Adhesion Drug Synergism Base Sequence Gene Expression Enzyme Activation Epithelial-Mesenchymal Transition Inhibitory Concentration 50 Transcription, Genetic Phenotype Protein Binding Genetic Predisposition to Disease Genes, Tumor Suppressor Time Factors Movement Cell Death Risk Tumor Microenvironment Radiation Tolerance Amino Acid Sequence DNA Damage Genes, Neoplasm Sensitivity and Specificity Genes, p53 Transcriptional Activation MAP Kinase Signaling System Odds Ratio Genotype Genetic Vectors DNA Methylation Epigenesis, Genetic Genes, BRCA1 Gene Expression Regulation, Enzymologic Autophagy Drug Resistance, Multiple

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science5

Molecular Sequence Data Base Sequence Survival Rate Registries Amino Acid Sequence

Named Groups1

Health Care16

Survival Analysis Survival Rate National Cancer Institute (U.S.)Retrospective Studies Follow-Up Studies Risk Prospective Studies Registries Disease-Free Survival Risk Assessment Sensitivity and Specificity Age Factors Kaplan-Meier Estimate Odds Ratio Reproducibility of Results Multivariate Analysis

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Sperm Motility Gastrointestinal Motility Breast Neoplasms Gene Expression Regulation, Neoplastic Cell Line, Tumor Cell Movement Neoplasm Invasiveness Tumor Cells, Cultured Cell Proliferation Colonic Neoplasms Apoptosis Mice, Nude Antineoplastic Agents Neoplasms Ovarian Neoplasms Lung Neoplasms RNA, Small Interfering Neoplasm Metastasis Pancreatic Neoplasms Early Detection of Cancer Drug Resistance, Neoplasm Cell Survival Neoplasm Proteins Signal Transduction Stomach Neoplasms Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays RNA, Messenger Drug Screening Assays, Antitumor Cell Division Down-Regulation Transfection Cell Cycle RNA Interference Neoplasm Transplantation HCT116 Cells MCF-7 Cells Cell Growth Processes Transplantation, Heterologous Prostatic Neoplasms HT29 Cells Gene Expression Profiling Mutation Phosphorylation Antineoplastic Agents, Phytogenic Carcinoma Dose-Response Relationship, Drug Tumor Suppressor Protein p53 Adenocarcinoma Up-Regulation Colorectal Neoplasms Receptors, Estrogen Gene Knockdown Techniques Receptor, erbB-2 Promoter Regions, Genetic Urinary Bladder Neoplasms Gene Silencing Cell Transformation, Neoplastic Cell Adhesion Tumor Markers, Biological Proto-Oncogene Proteins c-akt Carcinoma, Non-Small-Cell Lung Flow Cytometry Disease Progression Uterine Cervical Neoplasms Drug Synergism DNA, Neoplasm Models, Biological Molecular Sequence Data Carcinoma, Squamous Cell Cancer Vaccines Receptor, Epidermal Growth Factor Oligonucleotide Array Sequence Analysis Mice, SCID Tamoxifen Immunohistochemistry Cisplatin Neoplastic Stem Cells Prognosis Base Sequence Flagella Antineoplastic Combined Chemotherapy Protocols Gene Expression Neoplasms, Hormone-Dependent Cell Line Enzyme Activation Receptors, Androgen Enzyme Inhibitors Tumor Burden Tumor Suppressor Proteins RNA, Neoplasm Paclitaxel Transcription Factors MicroRNAs Proto-Oncogene Proteins Anticarcinogenic Agents Survival Analysis Epithelial-Mesenchymal Transition Androgens

No FAQ available that match "motility of cancer cells"